fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

Pazoo Creates A Subsidiary For Distributing And Marketing Of Non-Controlled Hemp Products

Published

on

Pazoo Inc. (OTCMKTS:PZOO) has announced that it has formed a fully owned subsidiary that is called CannabisKing Distribution LLC for sale and supply of products.

Establishment of a marketing and distribution subsidiary

The subsidiary has been established to act as a sales and marketing agent for the distribution and sale of the company’s nonregulated hemp products across the US. The non-controlled hemp products are those products that are normally employed in the industry to support grow facilities, dispensaries as well as infusion companies.

Pazoo already owns two other affiliates that have enhanced the creation of a strong relationship between the company and several growers as well as other industry related businesses. A number of product support associated companies are already made a request to partner with Pazoo through its distribution subsidiary to become a marketing and distribution channel for them. As a result of the increase in requests, Pazoo decided to create CannabisKing to handle the business.

Formation of CannabisKing a result of increasing demand

David Cunic the CEO of Pazoo stated that they were delighted and pleased to add another subsidiary company to their list. He added that CannabisKing was established because of an increase in demand from industry suppliers. Most of the demand came from the company’s online and social media presence as well as attending various expos and events. David added that most of the industry suppliers have realized that Pazoo has positioned itself well to create a significant footprint in the country and they thus want to access it through the growing relationships that the company is creating.

In other developments, the company’s Nevada subsidiary M&A Associates LLC is expected to host a grand opening of a Testing Lab in Las Vegas Nevada on June 3rd, 2019.  The Pazoo Fest’s first part will first be held between 3:30 to 7:00 PM in the Las Vegas laboratory on 2009 Western Avenue and it is open to everyone. The second part is scheduled to start at 6:00 PM and go on up to around 10:00 PM.

Continue Reading
Advertisement

CBD CONDITIONS & TREATMENTS

Cresco Labs Inc (OTCMKTS:CRLBF) Inaugurates VidaCann Dispensaries In Jacksonville And Pensacola And Expands Retail Footprint In Florida

Published

on

Cresco Labs Inc (OTCMKTS:CRLBF) has inaugurated new Vidacann medical cannabis dispensaries in Jacksonville and Pensacola cities in Florida. Co-founder and Chief Executive Officer of Cresco, Charlie Bachtell said since the takeover announced in March 2019, Vidacann has expanded its retail footprint in the state. The company will close the acquisition of Vidacann within 90 days.

12 dispensaries in Florida

With the opening of two new medical cannabis dispensaries, Vidacann now has 12 dispensaries in Florida. The most advanced and one of the biggest medical cannabis providers in Florida, Vidacann will improve the retail presence in the two biggest cities: Jacksonville and Pensacola by opening new dispensaries. Cresco will have the fifth biggest retail dispensaries network in Florida.

Cresco expects a weekly patient growth of 10,000 in Florida with the opening of new dispensaries in Pensacola and Jacksonville. It plans to increase the count of dispensaries in the state to 20 by 2029.

Cresco sets a revenue target of $1 billion

Cresco has become one of the multi-state operators in just 30 days with a couple of takeovers recently. The company announced accord to takeover Origin House in April 2019. As per the terms of the deal, the shareholders of Origin House will get 0.8428 shares of Cresco for each of their share in Origin House. The deal is valued at $1.1 billion CAD. It makes the biggest public company takeover in cannabis space in the US for Cresco.

Cresco has set a revenue target of $1 billion by the year 2021. Its Q3 2019 revenues are reported at $12 million. The company aims to become one of the biggest cannabis players in the world.

Cresco owns licenses in 51 retail locations and have access to 11 states following the takeover of Vidacann. The takeover of Origin House provides Cresco access to California distribution network of 50 brand relationships and 500 dispensary partners. Revenues from California market is expected at $7.7 billion by the year 2022.

Cresco will have access to New York, Michigan and Florida. These states together with California would offer a better opportunity for the company. With all these developments in place, the valuation of the stock are estimated at $4.1 billion.

Continue Reading

CBD CONDITIONS & TREATMENTS

Future Farm Technologies Inc (OTCMKTS:FFRMF) Completes Indoor Cultivation Stage And Expects To Produce 130,000 Pounds Of Biomass From 2019 Crop

Published

on

Future Farm Technologies Inc (OTCMKTS:FFRMF) has completed 2019 hemp for wellness crop’s indoor cultivation stage. The company is ready to transplant 200,000 seedlings in Hersey, Maine based 100 acre facility.

Expects yield of 130,000 pounds

Future Farm expects an output of 130,000 pounds of biomass from 2019 hemp crop. The company will transplant the seedlings at right time in the climate controlled indoor facility. Perfect timing of the seedlings will help to grow healthy plants and get higher yield of cannabidiol and other valuable bi-products.

Zero THC products

Future Farm will seek the help of processing providers to process biomass produced from the crop. The company will supply extracts, isolates, high quality distillates, zero THC products, and water-soluble products to the product manufacturers.

The Managers (Growing Operation) of Future Farm, Nate Gray and Zachary Lapan said they are confident of achieving a bumper 2019 crop with the application of experience gained in the inaugural 2018 harvest and processing.

Issues an update on Florida operations

Future Farm said its operations in Apopka, Florida based White Sand Nursery are in full swing. It started the 3 truckloads of spring accent plants shipments per week in March 2019 to one of the biggest customers in White Sand. The company expected to ship 850,000 3.5” plants in the first week of June 2019. Expected revenues from these shipments are estimated at $500,000. Future Farm is planning to fulfill the pre-booked orders of 845,000 plants from clients across the nation in fall season.

Chief Executive Officer of Future Farm, William Gildea said he is pleased with the accomplishments achieved by the management at White Sands. He is thrilled to ship truckloads of good quality products in a healthy condition.

Enters pact with Northeast Processing

Future Farm has signed an accord with Vermont based Northeast Processing for the processing, testing and packaging of its hemp cultivated in a Maine based 100 acre facility in 2019.

Northeast converts the Future Farm produced hemp biomass into CBD isolate, whole plant extract, and CBD distillate in just 4 months. Future Farm is searching for customers to supply its isolate, distillate and full spectrum extracts for wellness and health products.

Continue Reading

CBD CONDITIONS & TREATMENTS

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Expects Hemp Chaff Harvest Of 270,000 Kg From 1,200 Acres And Yield Of 3,500 Kg Extracted CBD In 2019 And Extends The Contract

Published

on

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) has extended the purchase contract with Emerald Health Hemp Inc (EHHI). As per the terms of the deal, Emerald will buy hemp flower and leaf from EHHI.

Expects harvest of 270,000 kg

Emerald expects harvest of 270,000 kg of hemp flower and leaf that will have 2% of CBD content from 1,200 acres in 2019. The company expects a yield of 3,500 kg of extracted CBD from harvested hemp. Emerald plans to manufacture softgels, premium oils, and other value-added products from extracted CBD for the medical and adult use markets.

Expects a sizable growth

Executive Chairman and President of Emerald, Dr. Avtar Dhillon said Emerald is well suited to become a leading manufacturer of high quality CBD products from harvested hemp in Canada using its processing capability and leveraging the alliance with Factors Group. The company will benefit from the production insights gained through establishing first its mover advantage in 2018 through securing large-scale hemp. Emerald is expected to achieve considerable growth in the near term in the market since it secured extended purchase contract.

Emerald purchased hemp chaff (134,000 kg) produced on 834 acres of EHHI in 2018. The approximate frozen and stored CBD content from this harvest is estimated at 1340 Kg. The company is fortunate to achieve this yield with the approval of Canadian government in 2018 allowing the use of whole hemp plants for commercial applications. The Canadian Government approval allows the companies that received licenses to extract CBD from hemp harvest.

Emerald is expecting an early harvest of hemp in 2019 in maturation cycle and benefit from higher CBD content. The company will process some hemp harvest in the manufacturing facility of Factors Group for gel encapsulation. It will process the balance hemp through extraction.

Improves sales by 131%

Emerald has reported sales of $2.6 million in Q1 2019. It represents an increase of 131% when compared to the previous quarter and a rise of 600% than last year. The company reduced the net loss to $3.6 million in Q1 2019 from $13.9 million in Q1 2018. Its medical cannabis client base has surged by 40%.

Emerald applauded the Canadian Government for releasing the regulations for edibles and ingestibles. It helps the company to introduce edibles, ingestibles and cape pens to the market.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories